These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 33420720)

  • 1. COVID-19-associated cutaneous manifestations: does human herpesvirus 6 play an aetiological role?
    Abadías-Granado I; Navarro-Bielsa A; Morales-Callaghan AM; Roc L; Suso-Estívalez CC; Povar-Echeverría M; Gilaberte Y
    Br J Dermatol; 2021 Jun; 184(6):1187-1190. PubMed ID: 33420720
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to 'Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases': vesicular eruption in COVID-19 - to exclude varicella.
    Lim SYD; Tey HL
    Br J Dermatol; 2020 Oct; 183(4):790-791. PubMed ID: 32613618
    [No Abstract]   [Full Text] [Related]  

  • 3. SARS-CoV-2 infection: the same virus can cause different cutaneous manifestations.
    Drago F; Ciccarese G; Rebora A; Muzic SI; Parodi A
    Br J Dermatol; 2020 Oct; 183(4):788. PubMed ID: 32533844
    [No Abstract]   [Full Text] [Related]  

  • 4. Herpesvirus and neurological manifestations in patients with severe coronavirus disease.
    Carneiro VCS; Alves-Leon SV; Sarmento DJS; Coelho WLDCNP; Moreira ODC; Salvio AL; Ramos CHF; Ramos Filho CHF; Marques CAB; da Costa Gonçalves JP; Leon LAA; de Paula VS
    Virol J; 2022 Jun; 19(1):101. PubMed ID: 35676707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral manifestations in coronavirus disease 2019 (COVID-19).
    Vieira AR
    Oral Dis; 2021 Apr; 27 Suppl 3(Suppl 3):770. PubMed ID: 32506730
    [No Abstract]   [Full Text] [Related]  

  • 6. Presence and clinical impact of human herpesvirus-6 infection in patients with moderate to critical coronavirus disease-19.
    Lino K; Alves LS; Raposo JV; Medeiros T; Souza CF; Silva AAD; de Paula VS; Almeida JR
    J Med Virol; 2022 Mar; 94(3):1212-1216. PubMed ID: 34647632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granuloma annulare triggered by SARS-CoV-2 infection: Immunohistochemical staining.
    Monte-Serrano J; García-Gil MF; García-García M; Casas-Flecha I; Matovelle-Ochoa C; Ara-Martín M
    Dermatol Ther; 2021 May; 34(3):e14897. PubMed ID: 33599069
    [No Abstract]   [Full Text] [Related]  

  • 8. SARS-CoV-2 as possible inducer of viral reactivations.
    Ciccarese G; Parodi A; Drago F
    Dermatol Ther; 2020 Nov; 33(6):e13878. PubMed ID: 32558172
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cutaneous Manifestations Associated with COVID-19: A Narrative Review].
    Relvas M; Calvão J; Oliveira R; Cardoso JC; Gonçalo M
    Acta Med Port; 2021 Feb; 34(2):128-136. PubMed ID: 33315008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral enanthema in oral mucosa: A possible diagnostic challenge in the COVID-19 pandemic.
    Rocha BA; Souto GR; Grossmann SMC; de Aguiar MCF; de Andrade BAB; Romañach MJ; Horta MCR
    Oral Dis; 2021 Apr; 27 Suppl 3(Suppl 3):776-778. PubMed ID: 32521564
    [No Abstract]   [Full Text] [Related]  

  • 11. New-onset cutaneous kaposi's sarcoma following SARS-CoV-2 infection.
    Magri F; Giordano S; Latini A; Muscianese M
    J Cosmet Dermatol; 2021 Dec; 20(12):3747-3750. PubMed ID: 34731523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A viral rash: the impact of COVID-19 infection on the skin.
    Hay RJ
    Br J Dermatol; 2020 Jul; 183(1):1-2. PubMed ID: 32613651
    [No Abstract]   [Full Text] [Related]  

  • 13. 'Vesicular eruption in COVID-19 - to exclude varicella': reply from the authors.
    Català A; Galván Casas C; Carretero Hernández G; García-Doval I
    Br J Dermatol; 2020 Oct; 183(4):791. PubMed ID: 32613623
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection of SARS-CoV-2 in pets living with COVID-19 owners diagnosed during the COVID-19 lockdown in Spain: A case of an asymptomatic cat with SARS-CoV-2 in Europe.
    Ruiz-Arrondo I; Portillo A; Palomar AM; Santibáñez S; Santibáñez P; Cervera C; Oteo JA
    Transbound Emerg Dis; 2021 Mar; 68(2):973-976. PubMed ID: 32810370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of 3 COVID-19 Vaccines in Preventing SARS-CoV-2 Infections, January-May 2021, Aragon, Spain.
    Del Cura-Bilbao A; López-Mendoza H; Chaure-Pardos A; Vergara-Ugarriza A; Guimbao-Bescós J
    Emerg Infect Dis; 2022 Mar; 28(3):591-598. PubMed ID: 35195514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-mortem differential diagnosis from COVID-19: A case of fulminant myocarditis HHV-6 related.
    Colombo D; Cecannecchia C; Albore M; Taglietti F; Nardacci R; Bolino G; Del Nonno F
    Pathol Int; 2022 Jan; 72(1):75-78. PubMed ID: 34748677
    [No Abstract]   [Full Text] [Related]  

  • 17. Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain.
    García-Salido A; de Carlos Vicente JC; Belda Hofheinz S; Balcells Ramírez J; Slöcker Barrio M; Leóz Gordillo I; Hernández Yuste A; Guitart Pardellans C; Cuervas-Mons Tejedor M; Huidobro Labarga B; Vázquez Martínez JL; Gutiérrez Jimeno M; Oulego-Erróz I; Trastoy Quintela J; Medina Monzón C; Medina Ramos L; Holanda Peña MS; Gil-Antón J; Sorribes Ortí C; Flores González JC; Hernández Palomo RM; Sánchez Ganfornina I; Fernández Romero E; García-Besteiro M; López-Herce Cid J; González Cortés R;
    Crit Care; 2020 Nov; 24(1):666. PubMed ID: 33243303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin manifestations during the COVID-19 pandemic in the pediatric emergency department.
    Oliva Rodríguez-Pastor S; Martín Pedraz L; Carazo Gallego B; Galindo Zavala R; Lozano Sánchez G; de Toro Peinado I; Rodriguez Benjumea M; Mejias A; Núñez Cuadros E
    Pediatr Int; 2021 Sep; 63(9):1033-1037. PubMed ID: 33278056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comment on 'Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID-19': involvement of herpesvirus reactivations and adverse drug reactions in diverse cutaneous manifestations and overall disease severity of COVID-19.
    Shiohara T; Mizukawa Y
    J Eur Acad Dermatol Venereol; 2021 Feb; 35(2):e98-e100. PubMed ID: 32970885
    [No Abstract]   [Full Text] [Related]  

  • 20. Cutaneous manifestations in children with SARS-CoV-2 infection and/or COVID-19: what do we know after 10 months under this pandemic?
    Li H; Zhao Y; Zhou L
    Int J Dermatol; 2022 Jan; 61(1):39-45. PubMed ID: 34530491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.